US 6562942
Methods for treatment of diabetes using peptide analogues of insulin
expired A61KA61K38/00
Quick answer
US patent 6562942 (Methods for treatment of diabetes using peptide analogues of insulin) held by Neurocrine Biosciences, Inc. expires Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- Neurocrine Biosciences, Inc.
- Grant date
- Tue May 13 2003 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 08 2023 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 18
- CPC classes
- A61K, A61K38/00